1. Home
  2. CASI vs FKWL Comparison

CASI vs FKWL Comparison

Compare CASI & FKWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CASI
  • FKWL
  • Stock Information
  • Founded
  • CASI 1991
  • FKWL 1981
  • Country
  • CASI China
  • FKWL United States
  • Employees
  • CASI N/A
  • FKWL N/A
  • Industry
  • CASI Biotechnology: Pharmaceutical Preparations
  • FKWL Telecommunications Equipment
  • Sector
  • CASI Health Care
  • FKWL Utilities
  • Exchange
  • CASI Nasdaq
  • FKWL Nasdaq
  • Market Cap
  • CASI 58.8M
  • FKWL 58.1M
  • IPO Year
  • CASI 1996
  • FKWL 1996
  • Fundamental
  • Price
  • CASI $2.36
  • FKWL $4.91
  • Analyst Decision
  • CASI Strong Buy
  • FKWL
  • Analyst Count
  • CASI 1
  • FKWL 0
  • Target Price
  • CASI $6.00
  • FKWL N/A
  • AVG Volume (30 Days)
  • CASI 30.6K
  • FKWL 23.7K
  • Earning Date
  • CASI 11-15-2024
  • FKWL 02-12-2025
  • Dividend Yield
  • CASI N/A
  • FKWL N/A
  • EPS Growth
  • CASI N/A
  • FKWL N/A
  • EPS
  • CASI N/A
  • FKWL N/A
  • Revenue
  • CASI $22,055,000.00
  • FKWL $34,464,056.00
  • Revenue This Year
  • CASI N/A
  • FKWL N/A
  • Revenue Next Year
  • CASI $134.79
  • FKWL N/A
  • P/E Ratio
  • CASI N/A
  • FKWL N/A
  • Revenue Growth
  • CASI N/A
  • FKWL N/A
  • 52 Week Low
  • CASI $2.05
  • FKWL $2.69
  • 52 Week High
  • CASI $7.67
  • FKWL $5.30
  • Technical
  • Relative Strength Index (RSI)
  • CASI 33.52
  • FKWL 61.07
  • Support Level
  • CASI $2.27
  • FKWL $4.88
  • Resistance Level
  • CASI $2.73
  • FKWL $5.30
  • Average True Range (ATR)
  • CASI 0.24
  • FKWL 0.13
  • MACD
  • CASI 0.02
  • FKWL 0.00
  • Stochastic Oscillator
  • CASI 12.70
  • FKWL 57.14

About CASI CASI Pharmaceuticals Inc.

CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.

About FKWL Franklin Wireless Corp.

Franklin Wireless Corp is a provider of wireless solutions, including mobile hotspots, routers, and modems, as well as hardware and software products that support machine-to-machine (M2M) applications and the Internet of Things (IoT). Its M2M and IoT solutions include embedded modules, modems, and gateways built to deliver reliable always-on connectivity supporting a spectrum of applications. These products are designed to solve wireless connectivity challenges in a range of vertical markets, including video surveillance, digital signage, home security, oil and gas exploration, kiosks, fleet management, smart grid, vehicle diagnostics, and telematics.

Share on Social Networks: